Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 Mar;3(2):147–150. doi: 10.1128/cdli.3.2.147-150.1996

Evaluation of serological assays for identification of parvovirus B19 immunoglobulin M.

T Tolfvenstam 1, U Rudén 1, K Broliden 1
PMCID: PMC170264  PMID: 8991627

Abstract

Three different enzyme immunoassays (EIAs) (Parvoscan-B19, IBL parvovirus B19, and IDEIA parvovirus B19) and one immunofluorescence assay (Biotrin Parvo B19 IFA) were evaluated for detection of parvovirus B19 immunoglobulin M (IgM) antibodies in 203 clinical serum samples. An IgM antibody capture radioimmunoassay was used as a reference test. Serum specimens obtained from patients with clinical symptoms suggestive of parvovirus B19 infections were used to evaluate the sensitivities of the assays, which were shown to be comparable for the Biotrin IFA and IDEIA (97%) and lower for the other two EIAs (90%). In order to test the specificity of the assays, clinical serum samples with IgM antibodies against other viruses were examined, as well as sera with rheumatoid factor activity and sera from healthy pregnant women. The specificities of B19 IgM antibody detection were 96% for the Biotrin IFA, 96% for IDEIA, 90% for Parvoscan, and 88% for the IBL assay. These results show that all four assays can be recommended for diagnostic purposes, although false-positive results may be seen with other acute viral infections, healthy pregnant women, and rheumatoid factor-positive samples.

Full Text

The Full Text of this article is available as a PDF (163.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson L. J., Tsou C., Parker R. A., Chorba T. L., Wulff H., Tattersall P., Mortimer P. P. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol. 1986 Oct;24(4):522–526. doi: 10.1128/jcm.24.4.522-526.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson M. J., Davis L. R., Jones S. E., Pattison J. R., Serjeant G. R. The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent. J Hyg (Lond) 1982 Apr;88(2):309–324. doi: 10.1017/s0022172400070169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anderson M. J., Higgins P. G., Davis L. R., Willman J. S., Jones S. E., Kidd I. M., Pattison J. R., Tyrrell D. A. Experimental parvoviral infection in humans. J Infect Dis. 1985 Aug;152(2):257–265. doi: 10.1093/infdis/152.2.257. [DOI] [PubMed] [Google Scholar]
  4. Anderson M. J., Lewis E., Kidd I. M., Hall S. M., Cohen B. J. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond) 1984 Aug;93(1):85–93. doi: 10.1017/s0022172400060964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brown C. S., Salimans M. M., Noteborn M. H., Weiland H. T. Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system. Virus Res. 1990 Mar;15(3):197–211. doi: 10.1016/0168-1702(90)90028-a. [DOI] [PubMed] [Google Scholar]
  6. Brown T., Anand A., Ritchie L. D., Clewley J. P., Reid T. M. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet. 1984 Nov 3;2(8410):1033–1034. doi: 10.1016/s0140-6736(84)91126-7. [DOI] [PubMed] [Google Scholar]
  7. Bruu A. L., Nordbø S. A. Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19. J Clin Microbiol. 1995 May;33(5):1363–1365. doi: 10.1128/jcm.33.5.1363-1365.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cassinotti P., Schultze D., Wieczorek K., Schönenberger R., Siegl G. Parvovirus B19 infection during pregnancy and development of hydrops fetalis despite the evidence for pre-existing anti-B19 antibody: how reliable are serological results? Clin Diagn Virol. 1994 Apr;2(2):87–94. doi: 10.1016/0928-0197(94)90041-8. [DOI] [PubMed] [Google Scholar]
  9. Cohen B. J., Mortimer P. P., Pereira M. S. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg (Lond) 1983 Aug;91(1):113–130. doi: 10.1017/s0022172400060095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cubie H. A., Leslie E. E., Smith S., O'Neill H. J., Hart H., Cohen B. J., Inglis J. M. Use of recombinant human parvovirus B19 antigens in serological assays. J Clin Pathol. 1993 Sep;46(9):840–845. doi: 10.1136/jcp.46.9.840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Frickhofen N., Abkowitz J. L., Safford M., Berry J. M., Antunez-de-Mayolo J., Astrow A., Cohen R., Halperin I., King L., Mintzer D. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med. 1990 Dec 15;113(12):926–933. doi: 10.7326/0003-4819-113-12-926. [DOI] [PubMed] [Google Scholar]
  12. Gray J. J., Cohen B. J., Desselberger U. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity. J Virol Methods. 1993 Sep;44(1):11–23. doi: 10.1016/0166-0934(93)90003-a. [DOI] [PubMed] [Google Scholar]
  13. Gray J. J., Roth C., Swygart C., Desselberger U. Human parvovirus B19 serology with recombinant VP1 and VP2 antigens: diagnosis of acute infections by detecting B19-specific IgM and IgA antibodies. Clin Diagn Virol. 1994 Oct;2(6):331–341. doi: 10.1016/0928-0197(94)90003-5. [DOI] [PubMed] [Google Scholar]
  14. Kajigaya S., Shimada T., Fujita S., Young N. S. A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7601–7605. doi: 10.1073/pnas.86.19.7601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kurtz J. B., Anderson M. J. Cross-reactions in rubella and parvovirus specific IgM tests. Lancet. 1985 Dec 14;2(8468):1356–1356. doi: 10.1016/s0140-6736(85)92647-9. [DOI] [PubMed] [Google Scholar]
  16. Kurtzman G. J., Ozawa K., Cohen B., Hanson G., Oseas R., Young N. S. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med. 1987 Jul 30;317(5):287–294. doi: 10.1056/NEJM198707303170506. [DOI] [PubMed] [Google Scholar]
  17. Linde A., Kallin B., Dillner J., Andersson J., Jägdahl L., Lindvall A., Wahren B. Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis. J Infect Dis. 1990 May;161(5):903–909. doi: 10.1093/infdis/161.5.903. [DOI] [PubMed] [Google Scholar]
  18. Magnius L. O., Saleh L. H., Vikerfors T., Norder H. A solid-phase reverse immunosorbent test for the detection of enterovirus IgM. J Virol Methods. 1988 May;20(1):73–82. doi: 10.1016/0166-0934(88)90042-0. [DOI] [PubMed] [Google Scholar]
  19. Morey A. L., Keeling J. W., Porter H. J., Fleming K. A. Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol. 1992 Jul;99(7):566–574. doi: 10.1111/j.1471-0528.1992.tb13822.x. [DOI] [PubMed] [Google Scholar]
  21. Pattison J. R., Jones S. E., Hodgson J., Davis L. R., White J. M., Stroud C. E., Murtaza L. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet. 1981 Mar 21;1(8221):664–665. doi: 10.1016/s0140-6736(81)91579-8. [DOI] [PubMed] [Google Scholar]
  22. Salimans M. M., van Bussel M. J., Brown C. S., Spaan W. J. Recombinant parvovirus B19 capsids as a new substrate for detection of B19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay. J Virol Methods. 1992 Sep;39(3):247–258. doi: 10.1016/0166-0934(92)90098-x. [DOI] [PubMed] [Google Scholar]
  23. Weiland H. T., Salimans M. M., Fibbe W. E., Kluin P. M., Cohen B. J. Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant patient. Br J Haematol. 1989 Feb;71(2):300–300. doi: 10.1111/j.1365-2141.1989.tb04276.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES